Acquired haemophilia A after alemtuzumab therapy

Marieke van der Zwan, Frank W.G. Leebeek, Yorick Sandberg, Marieke J. H. A. Kruip, Dennis A. Hesselink

Haemophilia · 2020 · 10 citations · 7 references

DOIFull text

Open access

Concepts

Abstract

Treatment with alemtuzumab leads to a prolonged depletion of T-and B cells, natural killer cells, dendritic cells and monocytes. 1

References

7